• Login
    View Item 
    •   Home
    • University Hospitals of Leicester NHS Trust
    • CHUGGS
    • Urology
    • View Item
    •   Home
    • University Hospitals of Leicester NHS Trust
    • CHUGGS
    • Urology
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of EMERCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjectsProfilesView

    My Account

    LoginRegister

    Links

    About EMERPoliciesDerbyshire Community Health Services NHS Foundation TrustLeicester Partnership TrustNHS Nottingham and Nottinghamshire CCGNottinghamshire Healthcare NHS Foundation TrustNottingham University Hospitals NHS TrustSherwood Forest Hospitals NHS Foundation TrustUniversity Hospitals of Derby and Burton NHS Foundation TrustUniversity Hospitals Of Leicester NHS TrustOther Resources

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penis

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Author
    Morgan, Bruno
    Keyword
    penile neoplasms
    squamous call carcinoma
    vinflunine
    Date
    2022
    
    Metadata
    Show full item record
    DOI
    10.1038/s41416-021-01574-9
    Publisher's URL
    https://www.nature.com/articles/s41416-021-01574-9
    Abstract
    Background: We investigated the first-line activity of vinflunine in patients with penis cancer. Cisplatin-based combinations are commonly used, but survival is not prolonged; many patients are unfit for such treatment or experience toxicity that outweighs clinical benefit. Methods: Twenty-five patients with inoperable squamous carcinoma of the penis were recruited to a single-arm, Fleming-A'Hern exact phase II trial. Treatment comprised 4 cycles of vinflunine 320 mg/m2, given every 21 days. Primary endpoint was clinical benefit rate (CBR: objective responses plus stable disease) assessed after 4 cycles. Seven or more objective responses or disease stabilisations observed in 22 evaluable participants would exclude a CBR of <15%, with a true CBR of >40% being probable. Results: Twenty-two participants were evaluable. Ten objective responses or disease stabilisations were confirmed. CBR was 45.5%, meeting the primary endpoint; partial response rate was 27.3%. Seven patients received >4 cycles of vinflunine. Dose reduction or treatment delay was required for 20% of cycles. In all, 68% of patients experienced at least one grade 3 adverse event. Two deaths on treatment were not caused by disease progression. Conclusions: Pre-specified clinical activity threshold was exceeded. Toxicity was in keeping with experience in other tumours. Vinflunine merits further study in this disease. Trial registration: NCT02057913.
    Citation
    Nicholson, S., Tovey, H., Elliott, T., Burnett, S. M., Cruickshank, C., Bahl, A., Kirkbride, P., Mitra, A. V., Thomson, A. H., Vasudev, N., Venugopal, B., Slade, R., Tregellas, L., Morgan, B., Hassall, A., Hall, E., & Pickering, L. M. (2022). VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penis. British journal of cancer, 126(1), 34–41. https://doi.org/10.1038/s41416-021-01574-9
    Type
    Article
    URI
    http://hdl.handle.net/20.500.12904/15262
    Collections
    Cancer
    Urology

    entitlement

     
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.